503.6. Drug Use In Renal Disease

Why is proteinuria or albuminuria considered a primary early marker of structural kidney damage?

It precedes measurable changes in serum creatinine (SCr) and serum electrolyte levels.

What is a primary clinical cause of a false-positive result on a urine dipstick protein check?

A highly concentrated urine sample.

List four non-renal transient physiological factors that can cause falsely elevated urine protein on a spot check.

"1. Recent heavy exercise 2. Urinary tract infection (UTI) 3. Menstruation 4. Hematuria"

According to KDIGO staging, what value range defines Category A1 (normal to mildly increased) albuminuria on a spot Albumin-to-Creatinine Ratio (ACR)?

$< 30\text{ mg/g}$ (or $< 30\text{ mg/day}$ in a 24-hour urine collection)

What range of ACR defines Category A2 (moderately increased / microalbuminuria)?

$30 - 300\text{ mg/g}$ (or $30 - 300\text{ mg/day}$)

What threshold defines Category A3 (severely increased) albuminuria?

$> 300\text{ mg/g}$ (or $> 300\text{ mg/day}$)

What combination of electrolyte abnormalities in a patient with kidney disease may trigger the clinical decision to initiate dialysis?

Elevated serum sodium ($\uparrow\text{Na}$) accompanied by low serum bicarbonate/carbon dioxide ($\downarrow\text{CO}_2$ / metabolic acidosis).

What is the average normal GFR level in healthy young adult men versus healthy young adult women?

Men: $127 \pm 20\text{ mL/min/1.73 m}^2$; Women: $118 \pm 20\text{ mL/min/1.73 m}^2$.

What are the two formal diagnostic criteria required to define Chronic Kidney Disease (CKD)?

GFR $< 60\text{ mL/min/1.73 m}^2$ for $\ge 3$ months, or evidence of structural/functional kidney damage for $\ge 3$ months.

What four physiological property requirements must an ideal filtration marker satisfy to accurately measure GFR?

It must be freely filtered at the glomerulus, NOT tubularly secreted, NOT reabsorbed, and NOT metabolized by the kidney.

Why does clearance of endogenous serum creatinine tend to overestimate true GFR?

Creatinine undergoes variable active tubular secretion in addition to glomerular filtration.

How does progressive renal failure alter the relative contribution of tubular secretion to total creatinine excretion?

As renal function declines, tubular secretion of SCr increases, leading to greater overestimation of kidney function.

Name three medications that inhibit renal tubular secretion of creatinine, causing a 'pseudo' acute kidney injury.

Trimethoprim, dronedarone, and $\text{H}_2$-receptor antagonists (e.g., cimetidine).

Why can Cystatin C levels NOT be measured in the urine to calculate renal clearance?

Although freely filtered at the glomerulus, Cystatin C is completely metabolized in the renal tubules and is not excreted unchanged in urine.

Name three non-renal clinical factors that alter baseline serum Cystatin C concentrations.

Corticosteroid use, thyroid disease, and active malignancies.

What exogenous solute is considered the historical 'Gold Standard' marker for measuring GFR?

Inulin

What is the primary clinical contraindication or risk factor when using iothalamate or iohexol to measure GFR?

Iodine allergy (as both are iodine-containing radiocontrast agents).

What specific diagnostic advantage do radiolabeled markers (e.g., $^{125}\text{I}$-iothalamate, $^{99\text{m}}\text{Tc}$-DTPA) offer over routine blood filtration markers?

They can determine the individual functional contribution of each separate kidney.

State the Cockcroft-Gault equation for estimating creatinine clearance in men and women.

$$\text{CrCl (mL/min)} = \frac{(140 - \text{Age}) \times \text{Weight (kg)}}{72 \times \text{SCr (mg/dL)}} \times (0.85 \text{ if female})$$

What formula is used to calculate Ideal Body Weight (IBW) in male adult patients?

$$\text{IBW}_{\text{male}} = 50\text{ kg} + 2.3\text{ kg} \times (\text{Height in inches} - 60)$$

What formula is used to calculate Ideal Body Weight (IBW) in female adult patients?

$$\text{IBW}_{\text{female}} = 45.5\text{ kg} + 2.3\text{ kg} \times (\text{Height in inches} - 60)$$

What is the formula for Adjusted Body Weight (AdjBW) using a 40% correction factor?

$$\text{AdjBW} = \text{IBW} + 0.4 \times (\text{Actual BW} - \text{IBW})$$

Which weight descriptor should be plugged into the Cockcroft-Gault equation for an underweight patient ($\text{BMI} < 18.5\text{ kg/m}^2$)?

Actual Body Weight (ABW)

Which weight descriptor provides the least bias and highest accuracy in Cockcroft-Gault for normal weight patients ($\text{BMI } 18.5 - 24.9\text{ kg/m}^2$)?

Ideal Body Weight (IBW)

Which weight descriptor is recommended for Cockcroft-Gault calculations in overweight or obese patients ($\text{BMI} \ge 25\text{ kg/m}^2$)?

Adjusted Body Weight (AdjBW)

Why does the Cockcroft-Gault equation tend to overestimate measured 24-hour CrCl in patients with end-stage liver disease?

Hepatic dysfunction leads to reduced creatine synthesis and severe muscle wasting, resulting in falsely low baseline SCr.

How does pregnancy affect the correlation between Cockcroft-Gault estimated CrCl and 24-hour measured CrCl?

Cockcroft-Gault correlates well with measured 24-hour CrCl during pregnancy.

Why are standard GFR/CrCl estimation equations unreliable in Acute Kidney Injury (AKI) or unstable renal function?

SCr is not at steady state, and serum concentrations lag behind rapid changes in true renal filtration rate.

What is the Schwartz equation used to estimate creatinine clearance in pediatric populations?

$\text{CrCl (mL/min/1.73 m}^2\text{)} = \frac{\text{Length (cm)} \times k}{\text{SCr (mg/dL)}}$, where $k$ is an age-dependent proportionality constant.

Is rounding low SCr values (e.g., $< 0.6\text{ mg/dL}$) up to $1.0\text{ mg/dL}$ in elderly patients currently recommended when calculating CrCl?

No, rounding low SCr up to 1.0 is NOT recommended as it leads to underestimation of kidney function and potential subtherapeutic drug dosing.

What effect does the Isotope Dilution Mass Spectrometry (IDMS) standardization assay have on SCr measurement compared to older non-standardized assays?

IDMS produces a 5% to 20% lower SCr value compared to older assays (which leads to overestimation of CrCl if plugged directly into standard Cockcroft-Gault).

What is the primary structural difference between the CKD-EPI 2009 equation and the CKD-EPI 2021 eGFR equation?

The CKD-EPI 2021 equation completely omits the race coefficient while maintaining equivalent overall performance.

In what GFR range does the CKD-EPI equation show superior accuracy compared to the older MDRD study equation?

At higher GFR levels ($> 60\text{ mL/min/1.73 m}^2$).

When is calculating a combined eGFR using both creatinine and Cystatin C (CKD-EPI Cr-Cys) most clinically beneficial?

In patients with borderline eGFRs (to confirm or rule out CKD), acute diet changes, or extremes in muscle mass.

Why is Cockcroft-Gault CrCl preferred over CKD-EPI eGFR for renal drug dosage adjustments in clinical practice?

Most FDA-approved manufacturer package insert dosing recommendations were historically derived using the Cockcroft-Gault equation.

How does diabetic gastroparesis in CKD patients affect oral drug absorption kinetics?

It delays GI transit time, increasing $T_{\max}$ and delaying rate of absorption, but generally does NOT decrease the overall extent of absorption (AUC).

What mechanism causes elevated gastric pH in patients with advanced chronic kidney disease?

Urease enzymes convert excess salivary urea into ammonia in the stomach, buffering gastric acid.

Name two drugs used in renal failure whose oral bioavailability is reduced by elevated gastric pH.

Furosemide and ferrous sulfate (both require an acidic environment for optimal absorption).

Which cation-containing medications commonly prescribed in CKD cause reduced antibiotic absorption via chelate formation?

Calcium or magnesium antacids, aluminum hydroxide, ferrous sulfate, and sodium polystyrene sulfonate (binding tetracyclines and fluoroquinolones).

By what mechanism do magnesium hydroxide and sodium bicarbonate increase the oral absorption of weakly acidic drugs like ibuprofen or glipizide?

They increase gastric pH, which promotes ionization and enhances the water solubility and dissolution rate of weak acids.

How does CKD impact intestinal CYP3A4 activity and P-glycoprotein (P-gp) efflux pumps?

CKD causes a $> 30\%$ reduction in intestinal CYP450 activity and decreases intestinal P-gp transport, overall increasing drug oral bioavailability ($F$).

Name four oral drugs that display increased oral bioavailability in CKD due to reduced intestinal clearance.

Propranolol, felodipine, sertraline, and cyclosporine.

How can decreased plasma protein binding in CKD lead to decreased systemic drug availability during hepatic first-pass metabolism?

Reduced protein binding increases the free fraction of drug in portal blood, making more unbound drug accessible for hepatic extraction.

What is the mathematical relationship between Volume of Distribution ($V_d$), total dose, and plasma drug concentration ($C_p$)?

$$V_d = \frac{\text{Dose}}{C_p}$$

Only the _____ (bound or unbound) fraction of a drug in plasma is pharmacologically active and able to cross biological membranes.

Unbound (free)

Why can a 'normal' total plasma concentration of phenytoin lead to severe toxicity in a patient with severe CKD?

Hypoalbuminemia and uremic toxin displacement increase the free (unbound) fraction of phenytoin while total drug concentration appears normal.

What main plasma protein predominantly binds acidic drugs in the blood?

Albumin

List five acidic drugs that exhibit significantly reduced plasma protein binding in severe CKD.

Phenytoin, furosemide, warfarin, valproate, and salicylates (also penicillins, cephalosporins, barbiturates).

What circulating plasma protein binds most basic/alkaline drugs, and how are its levels affected by renal dysfunction?

$\alpha_1$-acid glycoprotein (AAG); its levels are often elevated in renal disease (as an acute-phase reactant).

List four basic/alkaline drugs whose plasma protein binding is generally unchanged or slightly increased in renal impairment.

Propranolol, morphine, oxazepam, and vancomycin.

How does uremia in Stage V CKD specifically alter digoxin pharmacokinetics?

Uremia decreases tissue binding of digoxin, which decreases its volume of distribution ($V_d$) by approximately 50%.

What adjustment must be made to the loading dose of digoxin when a patient's $\text{CrCl}$ falls below $15\text{ mL/min}$?

Administer 50% of the usual loading dose (due to the 50% reduction in $V_d$).

What happens to hepatic CYP450 gene expression and enzyme activity in chronic kidney disease?

Hepatic CYP450 gene expression and enzyme protein activity are reduced (partially inhibited by circulating uremic toxins).

Name four key hepatic CYP2C9 substrates that may experience reduced systemic metabolism in CKD.

Fluvastatin, ibuprofen, losartan, and warfarin.

Name four key hepatic CYP2C19 drug substrates whose metabolism is slowed in renal impairment.

Citalopram, diazepam, omeprazole, and lansoprazole (also pantoprazole).

Name four key CYP2D6 drug substrates that undergo decreased oxidative clearance in severe CKD.

Metoprolol, codeine, haloperidol, and amitriptyline (also dextromethorphan, paroxetine, propranolol).

Name four CYP3A4 substrates whose hepatic metabolism is significantly reduced by uremia.

Atorvastatin, simvastatin, cyclosporine, and tacrolimus (also alprazolam, nifedipine, zolpidem).

List four major Phase II metabolic pathways that are slowed in chronic kidney disease.

"1. Acetylation 2. Glucuronidation 3. Sulfation 4. Methylation"

Name four drugs whose hepatic glucuronidation is decreased in patients with advanced CKD.

Acetaminophen, morphine, lorazepam, and naproxen.

Name four medications that undergo clearance via direct metabolic breakdown within the renal parenchyma.

Insulin, acetaminophen, imipenem-cilastatin, and morphine (also oxytocin, salicylate, somatostatin, vasopressin).

Why do diabetic patients with progressive CKD often experience unpredictable episodes of severe hypoglycemia?

Renal parenchymal metabolism and clearance of exogenous/endogenous insulin are reduced, significantly prolonging insulin half-life.

How does reduced glomerular filtration rate affect the elimination half-life ($t_{1/2}$) of renally eliminated drugs?

It decreases renal clearance, thereby significantly prolonging the free-drug elimination half-life.

What happens to the active tubular secretion transport system in patients with advanced CKD?

Active tubular transport capacity is reduced and becomes easily saturated at lower drug concentrations.

List five organic ion medications that primarily rely on active tubular secretion for renal elimination.

Furosemide, ampicillin, trimethoprim, procainamide, and cimetidine (also salicylic acid, dopamine, neostigmine, quinidine).

How does probenecid decrease the renal clearance of penicillin?

Probenecid competitively inhibits organic anion transporter-mediated active tubular secretion of penicillin in the proximal tubule.

How does impairment of passive tubular reabsorption in CKD affect urinary concentrations of drugs like lithium or aspirin?

Reduced tubular reabsorption leads to increased urinary concentration and excretion of these drugs.

What neurotoxic metabolite of meperidine accumulates in renal failure, and what is its main clinical hazard?

Normeperidine; it has minimal analgesic activity and accumulates to lower the seizure threshold (causing CNS excitation and seizures).

What active metabolite of midazolam accumulates in renal failure, causing prolonged central nervous system depression?

$\alpha$-hydroxy-midazolam

Name four drugs (other than meperidine and midazolam) whose active metabolites accumulate in renal failure.

Morphine (morphine-6-glucuronide), allopurinol (oxypurinol), cefotaxime, and propranolol.

Why is the initial loading dose of most drugs usually kept UNCHANGED in patients with CKD?

Loading dose depends primarily on Volume of Distribution ($V_d$), which is generally unchanged in CKD for most medications (digoxin being a major exception).

When might a patient with CKD require a HIGHER than standard loading dose of a hydrophilic drug?

When the patient has significant fluid overload, generalized edema, or ascites that expands extracellular fluid volume ($V_d$).

What is the general mathematical formula for calculating a loading dose?

$$\text{Loading Dose} = [\text{Desired Concentration}] \times V_d \text{ (L/kg)} \times \text{IBW (kg)}$$

What is the primary peak/trough consequence of adjusting a maintenance regimen in renal failure by REDUCING the dose while keeping the interval constant?

It produces lower peak concentrations and higher trough concentrations.

What is the primary advantage of adjusting maintenance dosing by EXTENDING the dosing interval while keeping the dose amount constant?

It maintains peak-to-trough plasma concentration ratios similar to normal, matching the prolonged elimination half-life.

Which maintenance dose adjustment strategy (extending interval vs reducing dose) is preferred for drugs with a broad therapeutic index and long half-life?

Extending the dosing interval.

List the six sequential steps in the systematic approach to adjusting drug dosage regimens for patients with renal insufficiency.

"Step 1: Obtain patient history and demographic/clinical data.

Step 2: Estimate CrCl using Cockcroft-Gault.

Step 3: Review current medications.

Step 4: Calculate individualized regimen.

Step 5: Monitor parameters and drug levels.

Step 6: Revise regimen based on clinical response."

What proportion of patients with CKD Stage III–V in clinical studies received renal medication doses higher than recommended guidance?

More than $40\%$, receiving doses that were on average 2.5 times higher than recommended.

Why is relying solely on CrCl insufficient for managing all aspects of drug therapy in renal failure?

CKD alters non-renal clearance pathways, hepatic metabolism (CYP450 activity), oral drug absorption, protein binding, and active metabolite accumulation.